Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2017, Article ID 1683430, 8 pages
https://doi.org/10.1155/2017/1683430
Research Article

The Impact of Adherence and Instillation Proficiency of Topical Glaucoma Medications on Intraocular Pressure

1Clinical Pharmacy Unit, School of Pharmacy, College of Health Sciences, Mekelle University, Mekelle, Tigray, Ethiopia
2Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
3Department of Ophthalmology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia

Correspondence should be addressed to Tesfay Mehari Atey; te.ude.um@irahem.yafset

Received 17 March 2017; Revised 29 June 2017; Accepted 30 July 2017; Published 14 September 2017

Academic Editor: Kazuyuki Hirooka

Copyright © 2017 Tesfay Mehari Atey et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. A. McVeigh and G. Vakros, “The eye drop chart: a pilot study for improving administration of and compliance with topical treatments in glaucoma patients,” Clinical Ophthalmology, vol. 9, pp. 813–819, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. C. Tham, X. Li, T. Y. Wong, H. A. Quigley, T. Aung, and C. Y. Cheng, “Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis,” Ophthalmology, vol. 121, pp. 2081–2090, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. R. N. Weinreb and P. T. Khaw, “Primary open-angle glaucoma,” Lancet, vol. 363, pp. 1711–1720, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Sommer, J. M. Tielsch, J. Katz et al., “Racial differences in the cause-specific prevalence of blindness in East Baltimore,” The New England Journal of Medicine, vol. 325, p. 1412, 1991. View at Publisher · View at Google Scholar
  5. S. Kingman, “Glaucoma is second leading cause of blindness globally,” Bulletin of the World Health Organization, vol. 82, p. 887, 2004. View at Google Scholar
  6. F. Kyari, M. M. Abdull, A. Bastawrous, C. E. Gilbert, and H. Faal, “Epidemiology of glaucoma in sub-Saharan Africa: prevalence, incidence and risk factors,” Middle East African Journal Ophthalmology, vol. 20, pp. 111–125, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Alemu, L. A. Nelson, B. Kruft, J. A. Stewart, and W. C. Stewart, “Epidemiology of glaucoma in central Ethiopia,” International Journal Ophthalmology, vol. 2, pp. 168–173, 2009. View at Google Scholar
  8. P. P. Lee, J. W. Walt, L. C. Rosenblatt, L. R. Siegartel, and L. S. Stern, “Association between intraocular pressure variation and glaucoma progression: data from a United States chart review,” American Journal of Ophthalmology, vol. 144, pp. 901–907, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Tsai, A. L. Robin, and J. P. Smith, “An evaluation of how glaucoma patients use topical medications: a pilot study,” Transactions of the American Ophthalmological Society, vol. 105, pp. 29–35, 2007. View at Google Scholar
  10. G. P. Konstas, G. Maskaleris, S. Gratsonidis, and C. Sardelli, “Compliance and viewpoint of glaucoma patients in Greece,” Eye, vol. 14, pp. 752–756, 2000. View at Publisher · View at Google Scholar
  11. W. C. Stewart, A. G. P. Konstas, and N. Pfeiffer, “Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment,” Journal of Ocular Pharmacology and Therapeutics, vol. 20, pp. 461–469, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. T. P. G. M. Vries, R. H. Henning, H. V. Hogerzeil, and D. A. Fresle, Guide to Good Prescribing: A Practical Manual, World Health Organization, Geneva, Switzerland, 1st edition, 2009.
  13. J. Flach, “The importance of eyelid closure and nasolacrimal occlusion following the ocular instillation of topical glaucoma medications, and the need for the universal inclusion of one of these techniques in all patient treatments and clinical studies,” Transactions of the American Ophthalmological Society, vol. 106, pp. 138–145, 2008. View at Google Scholar
  14. R. Kholdebarin, R. J. Campbell, Y. P. Jin, and Y. M. Buys, “Multicenter study of compliance and drop administration in glaucoma,” Canadian Journal of Ophthalmology, vol. 43, pp. 454–461, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Sleath, A. L. Robin, D. Covert, J. E. Byrd, G. Tudor, and B. Svarstad, “Patient reported behavior and problems in using glaucoma medications,” Ophthalmology, vol. 113, pp. 431–436, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. J. L. Stone JL, A. L. Robin, G. D. Novack, D. W. Covert, and G. D. Cagle, “An objective evaluation of eyedrop instillation in patients with glaucoma,” Archives of Ophthalmology, vol. 127, pp. 732–736, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Lacey, H. Cate, and D. C. Broadway, “Barriers to adherence with glaucoma medications: a qualitative research study,” Eye, vol. 23, pp. 924–932, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Gupta, B. Patil, B. M. Shah, S. J. Bali, S. K. Mishra, and T. Dada, “Evaluating eye drop instillation technique in glaucoma patients,” Journal of Glaucoma, vol. 21, pp. 189–192, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Sleath, S. Blalock, D. Covert et al., “The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity,” Ophthalmology, vol. 118, pp. 2398–2402, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Popović-Suić, J. Sikić, N. Vukojević, B. Cerovski, M. Nasić, and R. Pokupec, “Target intraocular pressure in the management of glaucoma,” Collegium Antropologicum, vol. 29, Supplement 1, pp. 149–151, 2005. View at Google Scholar
  21. W. W. Daniel and L. C. Cross, Biostatistics: A Foundation for Analysis in the Health Sciences, John Wiley and Sons Inc., Hoboken, NJ, USA, 8th edition, 2005.
  22. D. E. Morisky, A. Ang, M. Krousel-Wood, and H. J. Ward, “Predictive validity of a medication adherence measure in an outpatient setting,” Journal of Clinical Hypertension, vol. 10, pp. 384–354, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. D. E. Morisky, A. Ang, M. Krousel-Wood, and H. Ward, “Predictive validity of a medication adherence measure for hypertension control,” Journal of Clinical Hypertension, vol. 10, pp. 348–354, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. M. A. Krousel-Wood, T. Islam, L. S. Webber, R. S. Re, D. E. Morisky, and P. Muntner, “New medication adherence scale versus pharmacy fill rates in seniors with hypertension,” The American Journal of Managed Care, vol. 15, pp. 59–66, 2009. View at Google Scholar
  25. D. E. Morisky and M. R. DiMatteo, “Improving the measurement of self-reported medication nonadherence: final response,” Journal of Clinical Epidemiology, vol. 64, pp. 262-263, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Shaw, “How to administer eye drops and ointments,” Nursing Times, vol. 110, pp. 16–18, 2014. View at Google Scholar
  27. T. Mehari, A. T. Giorgis, and W. Shibeshi, “Level of adherence to ocular hypotensive agents and its determinant factors among glaucoma patients in Menelik II Referral Hospital, Ethiopia,” BMC Opthalmology, vol. 16, p. 131, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Mehari, A. T. Giorgis, and W. Shibeshi, “Appropriateness and determinants of proper administration technique of ocular hypotensive agents among glaucoma patients in Menelik II Referral Hospital, Ethiopia,” Journal of Clinical Experimental Ophthalmology, vol. 7, p. 554, 2016. View at Publisher · View at Google Scholar
  29. C. August, “Visual standards: aspects and ranges of vision loss,” in Proceedings of the International Council of Ophthalmology, 2002.
  30. S. A. Taylor, S. M. Galbraith, and R. P. Mills, “Causes of non-compliance with drug regimens in glaucoma patients: a qualitative study,” Journal of Ocular Pharmacology and Therapeutics, vol. 18, pp. 401–409, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Tatham, U. Sarodia, F. Gatrad, and A. Awan, “Eye drop instillation technique in patients with glaucoma,” Eye, vol. 27, pp. 1293–1298, 2013. View at Publisher · View at Google Scholar · View at Scopus